SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 145,641.64 |
Enterprise Value ($M) | 212,766.64 |
Book Value ($M) | 87,975.00 |
Book Value / Share | 15.52 |
Price / Book | 1.66 |
NCAV ($M) | -83,695.00 |
NCAV / Share | -14.77 |
Price / NCAV | -1.74 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.03 |
Return on Assets (ROA) | 0.02 |
Return on Equity (ROE) | 0.04 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.73 |
Current Ratio | 1.00 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 43,223.00 |
Assets | 219,476.00 |
Liabilities | 126,918.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 8.97 | 0.97 | |
13G/A | State Street Corp | 5.10 | 1.03 | |
13G/A | BlackRock, Inc. | 7.70 | -1.83 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
5,479,246 | 25,183,185 | 21.76 | |
6,795,379 | 36,795,501 | 18.47 | |
8,575,748 | 31,678,771 | 27.07 | |
6,076,781 | 31,493,075 | 19.30 | |
(click for more detail) |
Similar Companies | |
---|---|
NUVB – Nuvation Bio Inc. | OGN – Organon & Co. |
PBH – Prestige Consumer Healthcare Inc. | PRGO – Perrigo Company plc |
QGEN – Qiagen N.V. |
Financial data and stock pages provided by
Fintel.io